Alzheimer’s, Delirium & Dementia
Verified · Sep 2026Dementia (major neurocognitive disorder) is a persistent, progressive decline in one or more cognitive domains severe enough to impair daily function — Alzheimer disease is its most common cause — whereas delirium is an acute, fluctuating disturbance of attention and awareness caused by an underlying medical condition, drug, or withdrawal.
The disorder behind the CAM screen, the months-backward test, the anticholinergic med review, the HELP bundle, the never-restrain rule, the sundowning routine, the wandering bracelet, and the reason a "positive UA" in a confused 84-year-old is not automatically a UTI.
What’s going wrong in the body
The normal physiology, where it fails, and why the body’s compensation backfires.
01 Delirium — a vulnerable brain meets an insult
Delirium is defined (DSM-5, as carried by StatPearls) as "a disturbance in attention and awareness that develops acutely and fluctuates in severity", with at least one additional cognitive disturbance, not better explained by pre-existing dementia, not occurring in coma, and with evidence that it is caused by a medical condition, substance intoxication, withdrawal, or a toxin. That last clause is the whole clinical program: delirium is a symptom of something else, and the something else is what you treat.
Two mechanistic chains run in parallel. The neurotransmitter chain: delirium is associated with decreased cholinergic activity and increased dopaminergic activity — the two pathways overlap and their balance is vital to attention, which is why anticholinergic drugs are such reliable precipitants. The neuroinflammation chain: a peripheral insult such as infection or surgery releases cytokines (IL-6, TNF-α, IL-1β) that disrupt the blood–brain-barrier endothelium, raising permeability; CNS inflammation, microglial activation, ischemia and neuronal death follow, and attention and arousal fail. Newer framing treats delirium as a disorder of brain connectivity — frontoparietal and thalamocortical circuits drop out — with oxidative stress, circadian/melatonin disruption and the glucocorticoid stress response feeding the loop.
Why does an 84-year-old with dementia become delirious from a bladder catheter while a 40-year-old shrugs off pneumonia? The vulnerability × insult model: predisposing factors (age > 70, dementia, sensory loss, frailty, malnutrition, multimorbidity) reduce cognitive reserve, so a minor stressor — a minor procedure, catheterization — is enough to tip a highly vulnerable brain. In a resilient brain it takes a major insult. Dementia confers a 3–4-fold delirium risk, and roughly half of hospitalized people with dementia develop delirium superimposed on it.
02 Alzheimer disease — amyloid is the trigger, tau is the bullet
Alzheimer disease (AD) is a neurodegenerative condition of insidious onset and progressive impairment of memory, comprehension, language, attention, reasoning and judgment — and episodic short-term memory loss is the initial and most common presenting symptom, with long-term memory relatively spared. It is the most common form of dementia, accounting for roughly 60–80% of cases. Brain changes begin about two decades before symptoms; the preclinical stage is asymptomatic but already shows biomarker evidence (low CSF Aβ42, raised tau).
The amyloid chain: amyloid precursor protein (APP) is cleaved sequentially by β- and γ-secretase into the 42-amino-acid peptide Aβ42; rising Aβ42 aggregates, is toxic to neurons, and deposits as extracellular neuritic plaques — a core of amyloid surrounded by enlarged axonal endings. The tau chain: aggregated amyloid drives tau hyperphosphorylation; tau misfolds into twisted paired helical filaments and forms intracellular neurofibrillary tangles that first appear in the hippocampus, then spread to the cerebral cortex. StatPearls’ framing: amyloid is the trigger that initiates the disease, tau in the form of tangles is the bullet that produces neurodegeneration. Severity tracks tangles and synapse loss, not plaques — plaques can be found in cognitively normal people.
Two more chains explain the symptoms and the drugs. The cholinergic chain: neuronal loss in the nucleus basalis of Meynert reduces acetylcholine, and β-amyloid itself causes cholinergic synaptic loss and impaired ACh release — memory and learning fail, and this deficit is the entire rationale for cholinesterase inhibitors. The anatomy chain: neuronal death begins in the entorhinal cortex of the hippocampus, producing hippocampal and medial temporal atrophy, widened sulci and dilated lateral ventricles as the cortex thins. Genetics loads the gun: APOE ε4 roughly triples risk in heterozygotes and raises it about 15-fold in homozygotes (the most important sporadic risk factor); rare autosomal-dominant APP, PSEN1, PSEN2 mutations cause early-onset disease; and Down syndrome (an extra APP copy on chromosome 21) puts nearly 100% of people on the AD-pathology path.
03 Delirium versus dementia — the differentiation exams live on
Dementia is defined (DSM-5, via StatPearls) as a significant decline in at least one cognitive domain — executive function, complex attention, language, learning and memory, perceptual-motor, or social cognition — that is a change from baseline, is persistent and progressive, does not occur exclusively during delirium, and impairs everyday function (IADLs such as finances and medications, then ADLs such as grooming and feeding). Functional decline is not optional: no cognitive test alone diagnoses dementia. Mild cognitive impairment (MCI) is the step before — more memory trouble than peers without daily-life disruption; not everyone progresses, but roughly 10% per year do.
Set the two side by side, cell by cell as sourced. Onset: delirium acute, over hours to days; dementia insidious, over months to years. Course: delirium fluctuates within a day; dementia is progressive and, in the patient-page words, "almost never gets better." Attention: disturbed in delirium — it is the core deficit; relatively preserved early in dementia, where memory is the prominent deficit. Consciousness: altered in delirium (hypervigilant, drowsy, stuporous); normal wakefulness in dementia. Speech/thinking: incoherent, disorganized speech in delirium; word-finding trouble and anomia progressing over years to muteness in dementia. Perception: visual and tactile hallucinations common and fluctuating in delirium; subtype-dependent in dementia (rare early in AD, delusions in 20–40% of moderate AD, core visual hallucinations in Lewy body disease). Duration/reversibility: delirium variable and potentially reversible; dementia chronic and irreversible except the treatable mimics (normal pressure hydrocephalus, B12 deficiency, thyroid disease, syphilis, depression). EEG: generalized slowing in delirium versus an atrophy pattern in dementia.
The combination is the ward reality: delirium superimposed on dementia carries a pooled in-hospital prevalence near 49%, is missed by clinical teams in 60–72% of cases, and is a two-way street — dementia precipitates delirium, and delirium independently raises later dementia risk and accelerates decline in AD, sometimes for more than five years. So the single most important nursing habit on this page is to know the baseline from family or caregivers and treat any acute change from it as delirium — a medical problem to work up — not as "her dementia getting worse."
04 The other dementias — and why behavior is physiology too
DSM-5 lists 13 etiologic subtypes, and mixed pathology is common. Vascular dementia (≈ 15–20% of clinical diagnoses) results from ischemia or hemorrhage, not a proteinopathy: large-artery infarcts produce the classic stepwise decline, hypertensive arteriolosclerosis produces lacunes and microbleeds, and focal signs (hemiparesis, field cuts, gait failure) travel with the cognitive loss. Lewy body dementia — one of the most common dementias after AD and vascular — is α-synuclein misfolding with a cholinergic deficit more pronounced than in AD: fluctuating cognition and alertness, recurrent well-formed visual hallucinations, REM sleep behavior disorder, parkinsonism, early orthostatic hypotension and falls, and severe sensitivity to antipsychotics. Its fluctuations mimic delirium; the parkinsonism, dysautonomia and gradual onset separate them. By the 1-year rule, dementia first or within a year of the movement disorder is dementia with Lewy bodies; Parkinson disease ≥ 12 months earlier is Parkinson disease dementia. Frontotemporal dementia (mean presentation age 58, the second most common cause under 65) deposits TDP-43 or tau in the frontal and anterior temporal lobes: disinhibition, apathy, loss of empathy, compulsions, hyperorality — with memory intact early, so it is often mistaken for a psychiatric disorder. Cholinesterase inhibitors have no proven benefit in FTD.
Behavioral and psychological symptoms of dementia (BPSD) — delusions, hallucinations, apathy, anxiety, depression, disinhibition, agitation, wandering, sleep and appetite change — affect up to 97% of community-dwelling people with dementia at some point. They are not "bad behavior"; they are physiology plus unmet need. Sundowning, increased confusion and agitation from dusk through night in up to two-thirds of patients, is tied to degeneration of the suprachiasmatic nucleus, reduced melatonin and circadian disruption, amplified by fatigue, low light and shadows, reversed sleep and caregiver stress — and when it is new, think superimposed delirium. Agitation and aggression cluster around unmet needs (food, fluid, companionship), a mismatch between caregiver expectation and capability, and above all intimate care such as bathing, the primary precipitant of aggression. Pain is present in 46–56% of people with dementia, yet only 20–40% receive analgesics versus 60–80% of comparable people without dementia — the person who cannot say "it hurts" hits instead.
Causes & risk factors
Modifiable factors are teaching targets — the patient can act on them.
Signs & symptoms
Each finding tied to the mechanism that produces it — and the triage it calls for.
Diagnostics
Complications
Medications for this condition
Why each class is prescribed here — every card links to its full pharmacology page.
These exist because of the cholinergic chain: loss of nucleus basalis neurons starves the cortex of acetylcholine, so cholinesterase inhibitors (donepezil, rivastigmine, galantamine) block ACh breakdown to slow the worsening of symptoms — symptomatic only, they do not halt progression, benefit is modest and variable, and many patients and providers forgo them. Memantine, an NMDA antagonist that blunts glutamate excitotoxicity, is approved for moderate-to-severe AD and is often combined with a cholinesterase inhibitor. Disorder-specific traps: cholinesterase inhibitors cause bradycardia, conduction defects and syncope → falls (monitor heart rate and weight; avoid with sick sinus or active GI ulcer); they are the mainstay in Lewy body dementia, have no proven benefit in FTD, and are not recommended for delirium. Anti-amyloid antibodies are a separate class: lecanemab (FDA traditional approval July 2023) and donanemab (July 2024) slow decline by roughly 27–29% in early AD with confirmed amyloid, carry a boxed warning for ARIA (edema, microhemorrhage — headache, confusion, dizziness, seizures) and require APOE ε4 testing and serial MRI; aducanumab was discontinued in January 2024.
Mostly what these disorders are not treated with. In delirium there is no FDA-approved drug, and evidence "does not support the routine use of antipsychotics to shorten delirium duration, hasten cognitive recovery, or prevent new episodes" — use is restricted to severe agitation that threatens safety, at the lowest dose, adjusted daily, stopped as soon as feasible, with a baseline ECG and QTc monitoring; no pharmacotherapy is indicated for hypoactive delirium. In dementia they are the last step after pain, triggers, environment and non-drug measures, because of the boxed warning (≈ 1.6–1.7× mortality, 4.5% vs 2.6%) and stroke risk. Lewy body and Parkinson disease dementia: haloperidol is contraindicated; only quetiapine, pimavanserin or clozapine are considered. Benzodiazepines are worse still — they double falls and hip fractures and deepen delirium; their one delirium indication is alcohol or benzodiazepine withdrawal.
Beyond medications
- Delirium: find and fix the cause — "the main treatments for delirium are nonpharmacologic": stop or adjust the offending drug (reconcile with the pharmacist against AGS Beers 2023), treat infection and hypoxia, correct glucose, sodium and dehydration, relieve pain, constipation and urinary retention, remove the catheter, restore sleep. Treatment "focuses on the causes and symptoms of delirium," and "The first step is to identify the cause."
- HELP (Hospital Elder Life Program) bundle — six targets: reorientation (clocks, calendars, therapeutic activities), sleep (quiet, lights down, clustered care, no nighttime vitals or meds), early mobilization and tether removal, vision (eyeglasses on), hearing (aids in), hydration and feeding assistance — plus daily family presence. Cochrane 2021 (22 RCTs, 5,718 participants): multicomponent prevention cut delirium from 18.4% to 10.5%, RR 0.57 (95% CI 0.46–0.71), about a 43% reduction; HELP also cut falls 42%.
- ICU: the ABCDEF bundle — Assess and manage pain, Both spontaneous awakening and breathing trials, Choice of light sedation avoiding benzodiazepines, Delirium screening (CAM-ICU/ICDSC), Early mobility, Family engagement. Restraints are the last resort, shortest duration, only after behavioral measures fail — and verbal de-escalation comes first: calm, even tone, respect personal space, one person with one message, name the feeling, appeal to what the person wants.
- BPSD: the unmet-need sequence — safety check → rule out delirium (new illness, new drug, withdrawal) → characterize the behavior (onset, timing, triggers) → medication review → comfort (pain via PAINAD, constipation, retention) → environment (noise, temperature, over- or under-stimulation) → non-drug interventions (caregiver training, music, bright light, reminiscence, simple tasks, "Bathing without a Battle") → a drug trial only then, reassessed every 3–6 months. Redirect and reassure rather than correct.
- Sundowning routine — bathing, appointments and outings in the morning or early afternoon; consistent wake, meal and bedtime; maximize daytime sunlight and physical activity; limit napping, caffeine, alcohol and nicotine; larger lunch, lighter supper; well-lit evenings without shadows; no evening TV or chores; dark and quiet at night with no waking for vitals. No evidence for melatonin, trazodone, antihistamines or antipsychotics; avoid benzodiazepines; call the provider to rule out UTI, sleep apnea or a medication cause.
- Wandering & home safety — door and window alarms, deadbolts out of sight-line, camouflaged doors, night lights, hidden car keys and coats, structured daytime activity, basic needs met (toileting, food, fluids); ID bracelet with name, address and phone, GPS device, and a wandering response service (MedicAlert Safe & Found). At home: stove knobs off, knives and all medicines (including OTC) locked, firearms removed or locked away, hot-water temperature lowered, trip hazards gone, handrails and non-slip mats. Driving: people with dementia often do not notice their own driving problems, so family watches for the warning signs — new dents or scrapes, near misses, tickets or minor accidents, confusing the brake and gas pedals, speeding or driving too slowly, sudden lane changes, or a simple errand that takes far too long because the person got lost. A professional driving evaluation can help, state laws on dementia and driving vary (a few states require physicians to report the diagnosis), and driving can first be limited to short local trips in daylight. When it is no longer safe, the doctor can tell the person to stop, and the family can hide the keys or move or disable the car and arrange other transport (NIA).
- Late stage: hand feeding, respite, advance care planning — small pieces, finger foods, adaptive utensils, thickened liquids as needed, a distraction-free pleasant mealtime, and assisted oral feeding rather than a feeding tube. Caregiving is a health risk in its own right (BPSD raise caregivers’ psychiatric and cardiovascular disease), so screen for burnout and connect to respite services, adult day care, memory-care units and the Alzheimer’s Association 24/7 Helpline — caregiver training reduces BPSD and delays nursing-home placement. Settle advance directives, power of attorney and code status early, while the person can still state treatment goals.
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
How a real nurse thinks
The clinical-judgment loop, worked for a typical presentation — reasoning, not reference.
- 1 Recognize cues
The cues that matter are the changes from baseline: a woman who feeds herself and sleeps through the night is now drowsy by day, was awake and pulling lines all night, cannot sustain attention (months backward fails), and rambles — over hours, and fluctuating. Add the precipitant candidates sitting in plain sight: a new anticholinergic (diphenhydramine), three opioid doses, a catheter tether, undertreated pain (grimacing on movement), hyponatremia and a BUN of 34 suggesting dehydration, borderline hypoxia at 93%, no glasses or hearing aids, three days without a bowel movement, and post-fall, post-op status. The noise: repeating questions and needing help dressing — that is her baseline dementia, not the problem.
- 2 Analyze cues
Run the CAM: acute onset with fluctuation ✓, inattention ✓, disorganized thinking ✓, altered level of consciousness ✓ — CAM positive. This is delirium superimposed on dementia, not "her Alzheimer’s getting worse"; a demented brain has low reserve, so a hip fracture, surgery, a catheter and diphenhydramine are more than enough insult. The UA is the trap: leukocyte esterase alone with a negative nitrite, no fever and no urinary symptoms in an 84-year-old — where asymptomatic bacteriuria runs 40–50% — does not make this a UTI, and treating it would stop the hunt for the real, multiple causes.
- 3 Prioritize
The dangerous outcomes are the ones delirium buys: falls, a pulled catheter or line, aspiration, and the persistent cognitive loss that follows untreated delirium — plus the harm of the two "fixes" the night nurse proposed. Rule out the killers first (hypoxia, hypoglycemia, MI): SpO₂ 93% earns supplemental assessment and the ECG in the work-up set, glucose is 108. Then the removable precipitants in order of how fast they can go: the diphenhydramine order, the catheter, the pain, the fluids and sodium, the constipation. Haloperidol is not indicated — she is not a danger to herself or others beyond picking at lines — and restraints are a last resort that would add a precipitant.
- 4 Generate solutions
Nurse-owned now: glasses on, hearing aids in, blinds open, clock and calendar in view, call the daughter to sit at the bedside, breakfast assisted, out of bed to the chair with help, PAINAD score documented and scheduled analgesia clarified. SBAR to the provider anticipating: discontinue diphenhydramine, remove the catheter with a bladder scan afterward, reassess opioid dose against pain scores, complete the delirium work-up (CBC, CMP, ECG, chest radiograph), address sodium and hydration, a bowel regimen, and — per the asymptomatic-bacteriuria rule — hold antibiotics unless fever or urinary symptoms appear while the culture is pending. Pharmacist review of the full list against AGS Beers 2023.
- 5 Take action
Act, then call: environment and sensory aids fixed, daughter on her way, patient up to the chair, pain treated with the ordered analgesic before movement. Then the SBAR: "POD 1 hip repair, moderate Alzheimer’s at baseline: acute fluctuating confusion overnight, CAM positive with inattention and altered consciousness. Received diphenhydramine 2200 and three oxycodone doses; catheter in; Na 131, BUN 34, SpO₂ 93%; UA leukocyte esterase positive but nitrite negative, afebrile, no urinary symptoms. Requesting: discontinue diphenhydramine, catheter removal, delirium work-up, fluids review, bowel regimen, pain plan. I do not think she needs haloperidol or restraints." The trap avoided: sedating or tying down the symptom while the causes keep running — and starting an antibiotic for bacteriuria.
- 6 Evaluate
Success over the next 24–72 hours: repeat CAM each shift trending toward negative — attention returning (months backward improving), sleeping at night and awake by day, eating; catheter out with a normal bladder scan; sodium and BUN correcting; bowel movement; pain controlled at rest and with movement; no falls, no pulled lines, no restraints, no antipsychotic. Prepare the daughter honestly: treating the cause often brings recovery, but it can take weeks or sometimes months, and it may not be complete — which is exactly why the causes were chased on day one. Re-escalation triggers: a fever or dysuria (now the UA means something), a new focal deficit, or deepening somnolence.
Scenario — you’re the nurse
Work each question before revealing the answer. Rationales explain the wrong options too.
An 84-year-old woman with moderate Alzheimer disease, admitted after a fall at home with a hip fracture repaired yesterday. Her daughter describes the baseline: pleasant, oriented to person, repeats questions, needs help choosing clothes and bathing but feeds herself, sleeps through the night. Orders: oxycodone PRN, diphenhydramine 25 mg at bedtime (added on admission for sleep), IV fluids, indwelling urinary catheter from the OR still in place. Night report: "She was up all night pulling at her IV and catheter, didn’t know where she was — I think she needs a haloperidol order or wrist restraints."
Q1 Select all that apply Which findings indicate delirium rather than the patient’s baseline dementia? Select all that apply. - A. Confusion that developed over hours and varies through the day
- B. Inability to recite the months of the year backward
- C. Awake all night pulling at lines, drowsy and drifting off by morning
- D. Repeating the same questions to the nurse
- E. Needing help to choose clothing and bathe
Reveal answer & rationale
Q2 Multiple choice The night nurse asks the day nurse to request a haloperidol order "so she stops pulling at her lines." The best response is: - A. "Good idea — haloperidol is the standard treatment for delirium."
- B. "Let’s ask for lorazepam instead; it is safer in older adults."
- C. "Her agitation is a symptom — let’s find and fix the causes first: the diphenhydramine, the catheter, her pain, and her fluids. Antipsychotics are reserved for severe agitation that threatens safety."
- D. "Soft wrist restraints would protect the lines without any drug."
Reveal answer & rationale
Q3 Put in order Put the nurse’s first four actions in priority order: - A. Notify the provider (SBAR) with the CAM-positive findings, requesting discontinuation of diphenhydramine, catheter removal, and the delirium work-up
- B. Verify oxygenation and glucose and check for chest pain or ECG changes — rule out hypoxia, hypoglycemia, and MI
- C. Put on her glasses and hearing aids, open the blinds, place a clock and calendar in view, and call the daughter to the bedside
- D. Document the CAM result, PAINAD score, and the plan of care
Reveal answer & rationale
Q4 Multiple choice The urinalysis returns leukocyte esterase positive, nitrite negative, 5–10 WBC/hpf. The patient is afebrile with no dysuria, suprapubic pain, or new incontinence. The nurse should recognize that: - A. The confusion is explained — a UTI is confirmed and antibiotics should start now
- B. Bacteriuria without urinary symptoms is common after age 80 and does not by itself explain the delirium; keep hunting the other causes and hold antibiotics unless fever or urinary symptoms appear
- C. The urinalysis is normal and the culture can be cancelled
- D. A CT of the head is now the next required test
Reveal answer & rationale
Q5 Multiple choice The daughter asks, "Is this her Alzheimer’s getting worse? Will she come back to how she was?" The best response is: - A. "Yes — this is the next stage of her Alzheimer’s disease."
- B. "Once we treat the cause she will be exactly as she was within 24 hours."
- C. "This is delirium — a sudden, separate problem caused by her surgery, medicines and illness. Treating the causes often brings improvement, though recovery can take weeks or even months and may not be complete."
- D. "There is no way to know; a medication to calm her is the most helpful thing now."
Reveal answer & rationale
Common questions
What causes alzheimer’s, delirium & dementia?
What are the early signs of alzheimer’s, delirium & dementia?
Which findings should a nurse report immediately in alzheimer’s, delirium & dementia?
What is the difference between delirium and dementia?
Can hospital delirium be prevented?
Why aren’t antipsychotics the answer for agitation in dementia or delirium?
Sources
- Delirium — StatPearls — StatPearls (NCBI Bookshelf)
- Differentiating Delirium Versus Dementia in Older Adults — StatPearls — StatPearls (NCBI Bookshelf)
- Alzheimer Disease — StatPearls — StatPearls (NCBI Bookshelf)
- Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients (Burton et al., Cochrane 2021 — abstract) — Cochrane Database of Systematic Reviews (PubMed)
- American Geriatrics Society Choosing Wisely: five things healthcare providers and patients should question — American Geriatrics Society / J Am Geriatr Soc (PMC)
- FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval (lecanemab) — U.S. Food and Drug Administration
- Delirium — MedlinePlus — MedlinePlus (NLM)
- Alzheimer's Disease — MedlinePlus — MedlinePlus (NLM)
- Aducanumab to Be Discontinued as Alzheimer's Treatment — Alzheimer's Association — Alzheimer's Association
- Wandering — Alzheimer’s Association — Alzheimer's Association
- Driving Safety and Alzheimer’s Disease — National Institute on Aging (NIA) — National Institute on Aging (NIH)
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Scenarios are fictional teaching cases. Always verify against current guidelines and your institution's protocols before acting in practice. Not medical advice.